Immune Checkpoint Blockade Improves Chemotherapy in the PyMT Mammary Carcinoma Mouse Model
Despite the success of immune checkpoint blockade in cancer, the number of patients that benefit from this revolutionary treatment option remains low. Therefore, efforts are being undertaken to sensitize tumors for immune checkpoint blockade, which includes combining immune checkpoint blocking agent...
Main Authors: | Evelyn Sirait-Fischer, Catherine Olesch, Annika F. Fink, Matthias Berkefeld, Arnaud Huard, Tobias Schmid, Kazuhiko Takeda, Bernhard Brüne, Andreas Weigert |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01771/full |
Similar Items
-
Sphingosine-1-Phosphate and Macrophage Biology—How the Sphinx Tames the Big Eater
by: Andreas Weigert, et al.
Published: (2019-07-01) -
Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation
by: Catherine Olesch, et al.
Published: (2017-01-01) -
Macrophage Polarization In The Tumor Microenvironment
by: Bernhard Brüne, et al.
Published: (2015-08-01) -
Sphingosine Kinases are Involved in Macrophage NLRP3 Inflammasome Transcriptional Induction
by: Shahzad Nawaz Syed, et al.
Published: (2020-07-01) -
Lysosome-Dependent LXR and PPARδ Activation Upon Efferocytosis in Human Macrophages
by: Ana Carolina Mota, et al.
Published: (2021-05-01)